Veradigm 

$4.8
24
+$0.05+1.05% 今天

统计

当日最高
4.89
当日最低
4.8
52周高点
6
52周低点
3
成交量
9,961
平均成交量
227,096
市值
519.67M
市盈率
-
股息率
-
股息
-

即将到来

股息

0%股息率
Oct 8
$5.23
10年增长
不适用
5年增长
不适用
3年增长
不适用
1年增长
不适用

财报

27Feb预期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
0.05
0.14
0.22
0.31
预期EPS
0.07
实际EPS
不适用

财务

-14.7%利润率
未盈利
2017
2018
2019
2020
2021
2022
1.18B营收
-172.92M净利润

其他人也在关注

此列表基于在 Stock Events 上关注 MDRX 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Show more...
首席执行官
Ms. Tejal Vakharia J.D.
员工
2450
国家
US
ISIN
US01988P1084

上市

0 Comments

分享你的想法

FAQ

Veradigm 今天的股价是多少?
MDRX 当前价格为 $4.8 USD,过去 24 小时上涨了 +1.05%。在图表上更密切关注 Veradigm 股价表现。
Veradigm 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Veradigm 的股票以代码 MDRX 进行交易。
Veradigm 的股价在上涨吗?
MDRX 股票较上周下跌 -2.04%,本月上涨 +5.49%,过去一年 Veradigm 下跌 -12.09%。
Veradigm 的市值是多少?
今天 Veradigm 的市值为 519.67M
Veradigm 下一次财报日期是什么时候?
Veradigm 将于 二月 27, 2026 发布下一次财报。
Veradigm 上一季度的财报怎么样?
MDRX 上季度财报为每股 0.05 USD,预估为 0.05 USD,带来 +0% 的意外。下季度预估财报为每股 不适用 USD。
Veradigm 去年的营收是多少?
Veradigm 去年的营收为 1.18BUSD。
Veradigm 去年的净利润是多少?
MDRX 去年的净收益为 -172.92MUSD。
Veradigm 会发放股息吗?
是的,MDRX 的股息每 zh 发放一次。每股最新股息为 5.23 USD。截至今日,股息率(FWD)% 为 0%。
Veradigm 有多少名员工?
截至二月 02, 2026,公司共有2,450名员工。
Veradigm 属于哪个行业?
Veradigm从事于Health Care行业。
Veradigm 何时完成拆股?
Veradigm 最近没有进行任何拆股。
Veradigm 的总部在哪里?
Veradigm 的总部位于 US 的 Chicago。